ADvantage Therapeutics Inc.

ADvantage Therapeutics develops therapies to treat neurodegenerative conditions focusing on Alzheimer’s Disease. The company is developing potentially paradigm-changing therapies to treat AD in its labs at the Vienna BioCenter.